{"title":"阿片类药物使用障碍住院患者中重度抑郁症延长住院时间","authors":"Adeolu Funso Oladunjoye , Crystal Obi-Azuike , Funmilola Babalola , Gibson Anugwom , Henry Onyeaka , Kammarauche Aneni , Eduardo D. Espiridion","doi":"10.1016/j.psycom.2023.100118","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Depression is a risk factor for opioid use disorder (OUD). Addressing the dual care needs of patients with co-morbid Major Depressive disorder (MDD) and OUD is vital in improving clinical outcomes among this patient population. The aim of this study is to assess the impact of MDD on the hospital length of stay (LOS) of adults admitted with primary diagnosis of OUD.</p></div><div><h3>Methods</h3><p>We used the Nationwide Inpatient Sample (NIS) from January 1, 2016–December 31, 2019. We conducted univariate and multivariate analyses to determine association between MDD and hospital LOS among hospitalizations with OUD.</p></div><div><h3>Results</h3><p>6.9% of hospitalizations with OUD had a comorbid diagnosis of MDD. The association of MDD with longer LOS persisted after adjusting for age, sex, race, type of insurance and severity of illness (OR 2.86, 95% CI 2.69–3.04). Major and extreme severity of illness scores had 2.0- and 4.2-times higher odds for longer hospital LOS compared to milder severity of illness scores.</p></div><div><h3>Conclusions</h3><p>Comorbid diagnosis of MDD is an independent risk factor of longer hospital LOS among hospitalizations with OUD. Treatment modalities which coordinate mental health conditions and substance use therapies are needed for more effective outcomes including reducing long hospital stays, relapse and enhancing recovery.</p></div>","PeriodicalId":74595,"journal":{"name":"Psychiatry research communications","volume":"3 2","pages":"Article 100118"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Major Depressive Disorder prolongs hospital stay among hospitalizations with Opioid Use Disorder\",\"authors\":\"Adeolu Funso Oladunjoye , Crystal Obi-Azuike , Funmilola Babalola , Gibson Anugwom , Henry Onyeaka , Kammarauche Aneni , Eduardo D. Espiridion\",\"doi\":\"10.1016/j.psycom.2023.100118\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Depression is a risk factor for opioid use disorder (OUD). Addressing the dual care needs of patients with co-morbid Major Depressive disorder (MDD) and OUD is vital in improving clinical outcomes among this patient population. The aim of this study is to assess the impact of MDD on the hospital length of stay (LOS) of adults admitted with primary diagnosis of OUD.</p></div><div><h3>Methods</h3><p>We used the Nationwide Inpatient Sample (NIS) from January 1, 2016–December 31, 2019. We conducted univariate and multivariate analyses to determine association between MDD and hospital LOS among hospitalizations with OUD.</p></div><div><h3>Results</h3><p>6.9% of hospitalizations with OUD had a comorbid diagnosis of MDD. The association of MDD with longer LOS persisted after adjusting for age, sex, race, type of insurance and severity of illness (OR 2.86, 95% CI 2.69–3.04). Major and extreme severity of illness scores had 2.0- and 4.2-times higher odds for longer hospital LOS compared to milder severity of illness scores.</p></div><div><h3>Conclusions</h3><p>Comorbid diagnosis of MDD is an independent risk factor of longer hospital LOS among hospitalizations with OUD. Treatment modalities which coordinate mental health conditions and substance use therapies are needed for more effective outcomes including reducing long hospital stays, relapse and enhancing recovery.</p></div>\",\"PeriodicalId\":74595,\"journal\":{\"name\":\"Psychiatry research communications\",\"volume\":\"3 2\",\"pages\":\"Article 100118\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychiatry research communications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S277259872300017X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatry research communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S277259872300017X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:抑郁症是阿片类药物使用障碍(OUD)的危险因素。解决重度抑郁症(MDD)和OUD共病患者的双重护理需求对于改善该患者群体的临床结果至关重要。本研究的目的是评估重度抑郁症对初步诊断为OUD的成人住院时间(LOS)的影响。方法采用2016年1月1日至2019年12月31日的全国住院患者样本(NIS)。我们进行了单因素和多因素分析,以确定抑郁症住院患者中抑郁症和医院LOS之间的关系。结果6.9%的抑郁症住院患者有抑郁症的合并症诊断。在调整了年龄、性别、种族、保险类型和疾病严重程度后,MDD与较长LOS的关联仍然存在(OR 2.86, 95% CI 2.69-3.04)。与轻度疾病严重程度评分相比,严重和极端疾病严重程度评分的住院时间较长LOS的几率分别高出2.0倍和4.2倍。结论重度抑郁症的合并症诊断是OUD住院患者住院时间延长的独立危险因素。需要协调精神健康状况和药物使用疗法的治疗方式,以获得更有效的结果,包括减少长期住院时间、复发和加强康复。
Major Depressive Disorder prolongs hospital stay among hospitalizations with Opioid Use Disorder
Background
Depression is a risk factor for opioid use disorder (OUD). Addressing the dual care needs of patients with co-morbid Major Depressive disorder (MDD) and OUD is vital in improving clinical outcomes among this patient population. The aim of this study is to assess the impact of MDD on the hospital length of stay (LOS) of adults admitted with primary diagnosis of OUD.
Methods
We used the Nationwide Inpatient Sample (NIS) from January 1, 2016–December 31, 2019. We conducted univariate and multivariate analyses to determine association between MDD and hospital LOS among hospitalizations with OUD.
Results
6.9% of hospitalizations with OUD had a comorbid diagnosis of MDD. The association of MDD with longer LOS persisted after adjusting for age, sex, race, type of insurance and severity of illness (OR 2.86, 95% CI 2.69–3.04). Major and extreme severity of illness scores had 2.0- and 4.2-times higher odds for longer hospital LOS compared to milder severity of illness scores.
Conclusions
Comorbid diagnosis of MDD is an independent risk factor of longer hospital LOS among hospitalizations with OUD. Treatment modalities which coordinate mental health conditions and substance use therapies are needed for more effective outcomes including reducing long hospital stays, relapse and enhancing recovery.